The importance of adjuvant therapy in patients with node-positive prostate cancer: A nationwide validation studydoi:10.1016/j.urolonc.2016.07.020SDOSUrologic Oncology Seminars & Original Investigations
Patient selection All data were obtained from the surveillance, epidemiology, and end results (SEER) database, which provides information on cancer statistics to reduce the cancer burden among the US population18. The profiles of patients who underwent surgical treatment for MEC of the major salivary...
In conclusion, although the number of randomized patients is small, patients with small, genomic high-risk breast cancer did not seem to derive benefit from chemotherapy. Endocrine therapy was associated with improved outcomes even in genomic low-risk breast cancers....
Now investigators are diligently working to determine which of these agents is suitable for a given patient in each disease setting in the HER2-positive space and developing new agents and combinations to further improve efficacy without increasing toxicity. During a recent OncLive Peer Exchange, exper...
Epidemiological studies on non-small cell lung cancer (NSCLC) have noted RET fusions as an oncogenic driver. However, real-world data on RET biomarker test
Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer 1x 0:00 / 0:00 Subscribe to Podcast Key Points Question Is the omission of axillary dissection in patients with clinically node-positive breast cancer associated with systemic therapy in the upfront surgery and postneoadjuvant ...
interventions from home. For those who live in remote or culturally diverse areas, this availability could provide a unique quality of care and the option to choose how you want to receive support. Online therapy can help you apply the tools and principles of positive psychology to your own ...
Conclusions and Relevance This randomized clinical trial found that the CTC count may be a reliable biomarker method for guiding the choice between chemotherapy and endocrine therapy as the first-line treatment in hormone receptor–positive, ERBB2-negative metastatic breast cancer. Trial Registration Clin...
In the human patient, repeated infusions of donor B cells were safe and led to decreased levels of multiple inflammatory markers. "We were able to show that B cells, which can be readily obtained from the blood, could treat ALS in a well-established mouse model of the disease, and we ob...
doing the same thing as others do need not necessarily bring us success. One lung cancer patient (SK) told me: “I saw the oncologist. He told me to do the chemo… when I saw everybody do chemo, everybody do radiotherapy, I told myself… This must be the only way. I went back ...